OCCIDENT logo

OCCIDENT

Europe, Bayern, Germany, Munich

Description

The Entrepreneural Venture Capital Investor

Investor Profile

OCCIDENT has made 38 investments, with 1 in the past 12 months and 32% as lead.

Stage Focus

  • Series A (32%)
  • Series B (18%)
  • Seed (16%)
  • Series C (13%)
  • Series Unknown (11%)
  • Series D (8%)
  • Convertible Note (3%)

Country Focus

  • Switzerland (58%)
  • Germany (37%)
  • Finland (3%)
  • Slovenia (3%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical Device
  • Life Science
  • Therapeutics
  • Medical
  • Health Diagnostics
  • Pharmaceutical
  • Software
  • Electronics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does OCCIDENT frequently co-invest with?

BioMedPartners
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 3
Zürcher Kantonal Bank
Europe, Zurich, Switzerland, Zürich
Co-Investments: 11
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 13
H
Europe, Basel-Landschaft, Switzerland, Liestal
Co-Investments: 4
Verve Ventures
Europe, Zug, Switzerland, Zug
Co-Investments: 5
Alpana Ventures
Europe, Geneve, Switzerland, Geneva
Co-Investments: 5
European Innovation Council
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 3
coparion
Europe, Nordrhein-Westfalen, Germany, Cologne
Co-Investments: 3
Bayern Kapital
Europe, Bayern, Germany, Landshut
Co-Investments: 6
redalpine
Europe, Zurich, Switzerland, Zürich
Co-Investments: 4

Which angels does OCCIDENT often collaborate with?

Marius Nacht
Asia, Tel Aviv, Israel, Tel Aviv-yafo
Shared Deals: 1
TT
Europe, Slovenia
Shared Deals: 1
JG
Europe, Zurich, Switzerland
Shared Deals: 1
TD
North America, Washington, United States, Seattle
Shared Deals: 1
JS
Europe, Zurich, Switzerland, Zürich
Shared Deals: 1
JA
Europe, Hessen, Germany, Frankfurt
Shared Deals: 1
Shared Deals: 1
RC
Europe, England, United Kingdom, London
Shared Deals: 1

What are some of recent deals done by OCCIDENT?

Lymphatica Medtech

Ecublens, Vaud, Switzerland

Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.

BiotechnologyHealth CareMedicalMedical Device
Series BOct 8, 2024
Amount Raised: $19,646,128
Hemotune

Zürich, Zurich, Switzerland

Hemotune is a medical device company that develops a therapeutic blood purification platform for treatment of health ailments.

BiotechnologyHealth CareLife ScienceMedical DeviceTherapeutics
Series BMar 25, 2024
Amount Raised: $15,562,645
Tubulis

Munich, Bayern, Germany

Tubulis is a chemotherapeutic medication developer specializing in cancer and chronic disease treatment.

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics
Series BMar 14, 2024
Amount Raised: $139,300,472
Altavo

Dresden, Sachsen, Germany

Altavo operates as a medical device startup.

Health CareManufacturingMedical Device
Series AFeb 20, 2024
Amount Raised: $5,404,950
Chipmetrics

Joensuu, Eastern Finland, Finland

Nanotechnology, metrology

ElectronicsManufacturing
SeedJan 24, 2024
Amount Raised: $2,611,512
ReCatalyst

Ljubljana, Ljubljana Urban Commune, Slovenia

ReCatalyst develops next-generation PEM fuel cell catalysts.

ChemicalNanotechnology
SeedJul 12, 2023
Amount Raised: $1,893,895
EBAMed

Geneva, Geneve, Switzerland

EBAMed develops innovative solutions for non-invasive and automated treatment of heart arrhythmias by using ion beams.

Health Care
Series AJun 27, 2023
Amount Raised: $15,724,080
Lunaphore

Lausanne, Vaud, Switzerland

Lunaphore is a life sciences company that is creating technologies to enable spatial biology in all laboratories.

BiotechnologyHealth CareHealth DiagnosticsLife ScienceMedical Device
Series DMar 23, 2023
Amount Raised: $32,724,369
iThera Medical

München, Bayern, Germany

iThera Medical focuses on the development of proprietary MSOT technology for use in preclinical and clinical applications.

BiotechnologyHealth CareMedical
Series DDec 21, 2022
Amount Raised: $13,790,470
Resistell AG

Basel, Basel-Stadt, Switzerland

Resistell is a antibiotic resistance test.

Medical Device
Series BDec 20, 2022
Amount Raised: $9,175,580